These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35068790)

  • 41. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.
    Lerut J; Iesari S; Vandeplas G; Fabbrizio T; Ackenine K; Núñez MEI; Komuta M; Coubeau L; Ciccarelli O; Bonaccorsi-Riani E
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):412-422. PubMed ID: 31521538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early Allograft Dysfunction After Liver Transplantation With Donation After Circulatory Death and Brain Death Grafts: Does the Donor Type Matter?
    Mazilescu LI; Kotha S; Ghanekar A; Lilly L; Reichman TW; Galvin Z; Cattral MS; Bhat M; McGilvray ID; Sapisochin G; Sayed B; Selzner M; Selzner N
    Transplant Direct; 2021 Aug; 7(8):e727. PubMed ID: 34291149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.
    Li C; Mi K; Wen Tf; Yan Ln; Li B; Yang Jy; Xu Mq; Wang Wt; Wei Yg
    PLoS One; 2011; 6(11):e27366. PubMed ID: 22087299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparing High- and Low-Model for End-Stage Liver Disease Living-Donor Liver Transplantation to Determine Clinical Efficacy: A Systematic Review and Meta-Analysis (CHALICE Study).
    Jayant K; Cotter TG; Reccia I; Virdis F; Podda M; Machairas N; Arasaradnam RP; Sabato DD; LaMattina JC; Barth RN; Witkowski P; Fung JJ
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive utility of the C-reactive protein to albumin ratio in early allograft dysfunction in living donor liver transplantation: A retrospective observational cohort study.
    Park J; Lim SJ; Choi HJ; Hong SH; Park CS; Choi JH; Chae MS
    PLoS One; 2019; 14(12):e0226369. PubMed ID: 31821367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.
    Wan P; Yu X; Xia Q
    Liver Transpl; 2014 Apr; 20(4):425-36. PubMed ID: 24478109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Living Donor Liver Transplantation in a Cohort of Recipients With Left Ventricular Systolic Dysfunction.
    Bhangui P; Bhangui P; Aneja M; Sharma N; Gupta N; Soin AS; Vohra V
    J Clin Exp Hepatol; 2022; 12(4):1040-1047. PubMed ID: 35814511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early allograft dysfunction after living donor liver transplantation-current concepts and future directions.
    Agrawal D; Saigal S
    Liver Transpl; 2023 Aug; 29(8):871-884. PubMed ID: 37162155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive model and risk factors associated with a revised definition of early allograft dysfunction in liver transplant recipients.
    Nicolau-Raducu R; Cohen AJ; Bokhari A; Bohorquez H; Bruce D; Carmody I; Bugeaud E; Seal J; Sonnier D; Nossaman B; Loss G
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28856732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neutrophil Lymphocyte Ratio can Preempt Development of Sepsis After Adult Living Donor Liver Transplantation.
    Sarin S; Pamecha V; Sinha PK; Patil N; Mahapatra N
    J Clin Exp Hepatol; 2022; 12(4):1142-1149. PubMed ID: 35814504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The postoperative hepatic artery resistance index after living donor liver transplantation can predict early allograft dysfunction.
    Lv T; Kong L; Yang J; Wu H; Wen T; Jiang L; Yang J
    Medicine (Baltimore); 2020 Jan; 99(4):e18677. PubMed ID: 31977857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antegrade Arterial and Portal Flushing Versus Portal Flushing Only for Right Lobe Live Donor Liver Transplantation-A Randomized Control Trial.
    Pamecha V; Sandhyav R; Sinha PK; Bharathy KGS; Sasturkar S
    Transplantation; 2018 Apr; 102(4):e155-e162. PubMed ID: 29334530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early postoperative renal dysfunction in the adult living donor liver transplantation.
    Lee SK; Park JB; Kim SJ; Choi GS; Kim DJ; Kwon CH; Lee SK; Joh JW
    Transplant Proc; 2007 Jun; 39(5):1517-9. PubMed ID: 17580177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early allograft dysfunction and liver transplant outcomes: a single center retrospective study.
    Salvalaggio PR; Felga GE; Afonso RC; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2449-51. PubMed ID: 23026617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reassessment of Relevance and Predictive Value of Parameters Indicating Early Graft Dysfunction in Liver Transplantation: AST Is a Weak, but Bilirubin and INR Strong Predictors of Mortality.
    Fodor M; Woerdehoff A; Peter W; Esser H; Oberhuber R; Margreiter C; Maglione M; Cardini B; Resch T; Weissenbacher A; Sucher R; Zoller H; Tilg H; Öfner D; Schneeberger S
    Front Surg; 2021; 8():693288. PubMed ID: 34869549
    [No Abstract]   [Full Text] [Related]  

  • 59. Early post-operative acute phase response in patients with early graft dysfunction is predictive of 6-month and 12-month mortality in liver transplant recipients.
    Oweira H; Lahdou I; Daniel V; Opelz G; Schmidt J; Zidan A; Mehrabi A; Sadeghi M
    Hum Immunol; 2016 Oct; 77(10):952-960. PubMed ID: 27476050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
    Zimmerman MA; Baker T; Goodrich NP; Freise C; Hong JC; Kumer S; Abt P; Cotterell AH; Samstein B; Everhart JE; Merion RM
    Liver Transpl; 2013 Mar; 19(3):259-67. PubMed ID: 23495079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.